Clinical Trial Update: Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial of talaporfin sodium photodynamic therapy for advanced age-related macular degeneration has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Drugs mentioned

• talaporfin sodium (talaporfin sodium)

Snippet

Sponsor: Light Sciences LLC | Conditions: Macular Degeneration, Choroidal Neovascularization | Phase 1 | Status: TERMINATED